Upload abstract


0% Complete

    * Required

    Submission Guidelines

    • Abstracts can only be submitted electronically through the Congress website.
    • You are allowed to be the presenting author of more than one abstract.
    • You are allowed to be a co-author of more than one abstract.
    • Submission of similar abstracts from the same group is discouraged.
    • Abstracts will only be considered for presentation if they are not published or submitted for presentation elsewhere.

    Abstract Language and Length

    Abstracts and presentations must be written in English. The maximum length allowed for an abstract is 2500 characters (approximately 350 words) including blank spaces. The abstract title, the author(s) or names of institutions are not included in the count of 2500 characters.


    Tables are allowed – 50 characters per row will be deducted from the word count. Please note that it is not possible to upload pictures during the abstract submission. However, if your abstract has been accepted you are allowed to include pictures / clinical images in your presentation.

    Abstract Structure and Content

    In order to make the abstract as informative as possible, please include a brief statement of the purpose of the study and/or the underlying hypotheses, the method used, the results observed, and the conclusions based upon the results. It is inadequate to state “The results will be discussed” or “The data will be presented”. You may subtitle the paragraphs in the following order: Background, Method, Results, and Conclusion.

    The abstract title and body text should only include pharmacopoeia names printed in lower case. Trade names are not allowed. Non-proprietary (generic) names of drugs, written in lower case, are required the first time a drug is mentioned in the text. References, credits or the authors’ academic degrees or grant support are not to be included in the abstract. Standard abbreviations may be employed in the text. Place special or unusual abbreviations in parentheses after the full wording at the first time it appears in the body of the text. Company names are not allowed in the title but can be named in the authors’ affiliation.

    Duplication of Publications

    Abstracts will only be considered for presentation if they are not published or presented elsewhere.